Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever. Lassa fever is lethal in humans and ...
Lassa virus (LASV) is the pathogen that causes Lassa hemorrhagic fever, a disease endemic to West Africa, which causes approximately 5,000 deaths each year. At the CSSB Centre for Structural Systems ...
Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever. Lassa fever is lethal in humans and ...
Researchers report the results of the first ever genome-wide association study (GWAS) of a biosafety level 4 (BSL-4) virus. The team found two key human genetic factors that could help explain why ...
The Oxford Vaccine Group has vaccinated the first volunteer in a first-in-human trial of a Lassa vaccine. This Coalition for Epidemic Preparedness Innovations (CEPI)-funded trial is being conducted in ...
A new study led by researchers at the Institute for Global Health and Infectious Diseases at the University of North Carolina School of Medicine in Chapel Hill shows an urgent need for improved ...
A case of Lassa fever has been reported in Paris, France, sparking lurid warnings about the “horrific Ebola-like bug”. As the name suggests, Lassa fever causes a high temperature, but also weakness, ...
GALVESTON, TEXAS -- In a new study, researchers at the University of Texas Medical Branch show that a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever, provides rapid ...
Structure prediction of the nucleoprotein (NP) ring like structure in complex with the matrix protein Z (left). RNA can induce dissociation of the NP trimer which enables NP-RNA assemblies. Native ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results